BioSpace News Archive

Under the license, Monsanto plans to research both traits within its soybean pipeline as a strategy to improve plant yields.

Magenta Therapeutics announced the presentation of preclinical data from its hematopoietic stem cell (HSC) mobilization and expansion programs at the 59th annual meeting of the American Society of Hematology (ASH) in Atlanta, Ga.

Data show rapid and durable engraftment with MGTA-456, an expanded cord blood stem cell product, in all 18 patients with hematologic malignancies across all conditioning regimens tested.

Aptevo is developing APVO436 for the treatment of acute myeloid leukemia (AML), a form of blood and bone marrow cancer that is characterized by rapid disease progression.

The data were also simultaneously published online in the journal Blood.

In this role, Babusik will oversee and direct all development and innovation efforts for Ranir.

Creative Diagnostics recently launches flow cytometry for all bio-researchers focusing on scientific study.

Tiziana Life Sciences announces that the independent data monitor committee (IDMC) completed interim analysis of the safety and pharmacokinetic data from the first six patients and concluded that treatment with Milciclib was safe and well-tolerated with no drug-related serious adverse events (SAEs) in patients with unresectable or metastatic HCC.

Quanterix announced the closing of its initial public offering of 4,916,480 shares of common stock at a public offering price of $15.00 per share, including 641,280 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares.

Science Exchange announced the partnership with Bioinformatics Solutions to offer online access to its protein de novo sequencing services to scientists around the globe.